Clinical Trial

Effect of Dexmedetomidine on Lung Protection in Elderly Patients Undergoing Laparoscopic Surgery for Colorectal Cancer

Study acronym: Dex
Completed
View on ClinicalTrials.gov →
Summary
The primary change in aging lung tissue among older people is atrophy, leading to a significant decline in ventilatory function. Intraoperative mechanical ventilation further decreases lung compliance and ventilatory function in elderly patients, making them more susceptible to respiratory dysfunction and postoperative pulmonary complications, which severely affects patient safety and postoperative recovery. Dexmedetomidine is a highly selective α2-adrenergic receptor agonist, and several studies have found that intravenous infusion of dexmedetomidine exerted lung protective effects during single-lung ventilation thoracic surgery. However, one study found that continuous intravenous dexmedetomidine infusion during low-temperature cardiac arrest aortic surgery did not improve perioperative respiratory mechanics and oxygenation. Therefore, this project aims to investigate the lung protective effects of continuous intravenous infusion of dexmedetomidine during laparoscopic surgery for elderly patients with rectal or sigmoid colon cancer.
Trial Details
NCT Number NCT07385898
Lead Sponsor The Second Affiliated Hospital of Chongqing Medical University
Conditions Rectal Tumors, Tumor of Sigmoid Colon, Lung Injury, Surgery, Laparoscopic, Dexmedetomidine
Enrollment 64 participants
Start Date 2023-04-17
Primary Completion 2024-02-03 (estimated)
Study Completion 2024-02-27 (estimated)
Updated on ClinicalTrials.gov 2026-02-04